Impact Biomedical (IBO) Preferred Shares (2023 - 2025)
Impact Biomedical's (IBO) quarterly Preferred Shares came in at $60000.0 in Q3 2025, little changed YoY from $60000.0 in Q3 2024, and little changed on a QoQ basis from $60000.0 in Q2 2025.
Impact Biomedical (IBO) Preferred Shares (2023 - 2025) Analysis & Trends
Impact Biomedical (IBO) has 3 years of Preferred Shares data on file, last reported at $60000.0 in Q3 2025.
- Quarterly Preferred Shares changed 0.0% year-over-year to $60000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $60000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $60.5 billion, up 100826635.0% from the prior year.
- Preferred Shares steadied at $60000.0 in Q3 2025, from $60000.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $60.5 billion in Q4 2024 to a low of $60000.0 in Q4 2023.
- A 3-year average of $7.6 billion and a median of $60000.0 in 2023 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2024 — Preferred Shares soared 100826635.0% — and 2025, when it changed 0.0%.
- Tracing IBO's Preferred Shares over 3 years: stood at $60000.0 in 2023, then soared by 100826635.0% to $60.5 billion in 2024, then slumped by 100.0% to $60000.0 in 2025.
- The last three Preferred Shares figures came in at $60000.0 (Q3 2025), $60000.0 (Q2 2025), and $60000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Impact Biomedical | 49.54 Mn | 49.53 Mn | 2,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 60.50 Bn |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 60,000.00 |
| Dec 31, 2023 | 60,000.00 |